Survival for cancer patients in Europe

Arduino Verdecchia, Mariano Santaquilani, Milena Sant

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Comparing cancer survival among the European countries is important to evaluate the performance of Health Care Systems and reduce disparities in access to diagnostic and treatment facilities. The EUROCARE project compares survival in Europe since the nineties. The EUROCARE-4 analysed 2 690 922 adult cancer cases from 83 cancer registries in 22 European countries, diagnosed in 1995-1999, and followed to December 2003. For each cancer site, the European area weighted mean and age-standardised country-specific observed and relative survival by age and sex is computed. Within-country variation in survival is analysed for selected cancers. Survival for most solid cancers, whose prognosis depends largely on stage at diagnosis (breast, colorectal, stomach cancers, and skin melanoma), was highest in Finland, Sweden, Norway, and Iceland, lower in the UK and Denmark, and lowest in the Czech Republic, Poland and Slovenia. France, Switzerland and Italy generally had good survival, slightly below that of the Northern countries. For all cancers, five-year survival was very variable also for the different sites mix. Continuing to monitoring cancer survival in Europe is important to reduce differences in access to diagnostic and therapeutic facilities. After publication of EUROCARE results, UK and Denmark developed a National cancer plan to improve time of diagnosis and treatment.

Original languageEnglish
Pages (from-to)315-324
Number of pages10
JournalAnnali dell'Istituto Superiore di Sanita
Volume45
Issue number3
Publication statusPublished - 2009

Fingerprint

Survival
Neoplasms
Denmark
Slovenia
Iceland
Czech Republic
Skin Neoplasms
Poland
Finland
Norway
Switzerland
Sweden
Italy
Stomach Neoplasms
France
Registries
Publications
Colorectal Neoplasms
Melanoma
Breast

Keywords

  • Cancer registries
  • Cancer survival
  • Europe

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Verdecchia, A., Santaquilani, M., & Sant, M. (2009). Survival for cancer patients in Europe. Annali dell'Istituto Superiore di Sanita, 45(3), 315-324.

Survival for cancer patients in Europe. / Verdecchia, Arduino; Santaquilani, Mariano; Sant, Milena.

In: Annali dell'Istituto Superiore di Sanita, Vol. 45, No. 3, 2009, p. 315-324.

Research output: Contribution to journalArticle

Verdecchia, A, Santaquilani, M & Sant, M 2009, 'Survival for cancer patients in Europe', Annali dell'Istituto Superiore di Sanita, vol. 45, no. 3, pp. 315-324.
Verdecchia, Arduino ; Santaquilani, Mariano ; Sant, Milena. / Survival for cancer patients in Europe. In: Annali dell'Istituto Superiore di Sanita. 2009 ; Vol. 45, No. 3. pp. 315-324.
@article{03cd2b19272d4f7f924174fde66bf082,
title = "Survival for cancer patients in Europe",
abstract = "Comparing cancer survival among the European countries is important to evaluate the performance of Health Care Systems and reduce disparities in access to diagnostic and treatment facilities. The EUROCARE project compares survival in Europe since the nineties. The EUROCARE-4 analysed 2 690 922 adult cancer cases from 83 cancer registries in 22 European countries, diagnosed in 1995-1999, and followed to December 2003. For each cancer site, the European area weighted mean and age-standardised country-specific observed and relative survival by age and sex is computed. Within-country variation in survival is analysed for selected cancers. Survival for most solid cancers, whose prognosis depends largely on stage at diagnosis (breast, colorectal, stomach cancers, and skin melanoma), was highest in Finland, Sweden, Norway, and Iceland, lower in the UK and Denmark, and lowest in the Czech Republic, Poland and Slovenia. France, Switzerland and Italy generally had good survival, slightly below that of the Northern countries. For all cancers, five-year survival was very variable also for the different sites mix. Continuing to monitoring cancer survival in Europe is important to reduce differences in access to diagnostic and therapeutic facilities. After publication of EUROCARE results, UK and Denmark developed a National cancer plan to improve time of diagnosis and treatment.",
keywords = "Cancer registries, Cancer survival, Europe",
author = "Arduino Verdecchia and Mariano Santaquilani and Milena Sant",
year = "2009",
language = "English",
volume = "45",
pages = "315--324",
journal = "Annali dell'Istituto Superiore di Sanita",
issn = "0021-2571",
publisher = "Istituto Superiore di Sanita",
number = "3",

}

TY - JOUR

T1 - Survival for cancer patients in Europe

AU - Verdecchia, Arduino

AU - Santaquilani, Mariano

AU - Sant, Milena

PY - 2009

Y1 - 2009

N2 - Comparing cancer survival among the European countries is important to evaluate the performance of Health Care Systems and reduce disparities in access to diagnostic and treatment facilities. The EUROCARE project compares survival in Europe since the nineties. The EUROCARE-4 analysed 2 690 922 adult cancer cases from 83 cancer registries in 22 European countries, diagnosed in 1995-1999, and followed to December 2003. For each cancer site, the European area weighted mean and age-standardised country-specific observed and relative survival by age and sex is computed. Within-country variation in survival is analysed for selected cancers. Survival for most solid cancers, whose prognosis depends largely on stage at diagnosis (breast, colorectal, stomach cancers, and skin melanoma), was highest in Finland, Sweden, Norway, and Iceland, lower in the UK and Denmark, and lowest in the Czech Republic, Poland and Slovenia. France, Switzerland and Italy generally had good survival, slightly below that of the Northern countries. For all cancers, five-year survival was very variable also for the different sites mix. Continuing to monitoring cancer survival in Europe is important to reduce differences in access to diagnostic and therapeutic facilities. After publication of EUROCARE results, UK and Denmark developed a National cancer plan to improve time of diagnosis and treatment.

AB - Comparing cancer survival among the European countries is important to evaluate the performance of Health Care Systems and reduce disparities in access to diagnostic and treatment facilities. The EUROCARE project compares survival in Europe since the nineties. The EUROCARE-4 analysed 2 690 922 adult cancer cases from 83 cancer registries in 22 European countries, diagnosed in 1995-1999, and followed to December 2003. For each cancer site, the European area weighted mean and age-standardised country-specific observed and relative survival by age and sex is computed. Within-country variation in survival is analysed for selected cancers. Survival for most solid cancers, whose prognosis depends largely on stage at diagnosis (breast, colorectal, stomach cancers, and skin melanoma), was highest in Finland, Sweden, Norway, and Iceland, lower in the UK and Denmark, and lowest in the Czech Republic, Poland and Slovenia. France, Switzerland and Italy generally had good survival, slightly below that of the Northern countries. For all cancers, five-year survival was very variable also for the different sites mix. Continuing to monitoring cancer survival in Europe is important to reduce differences in access to diagnostic and therapeutic facilities. After publication of EUROCARE results, UK and Denmark developed a National cancer plan to improve time of diagnosis and treatment.

KW - Cancer registries

KW - Cancer survival

KW - Europe

UR - http://www.scopus.com/inward/record.url?scp=70350304610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350304610&partnerID=8YFLogxK

M3 - Article

VL - 45

SP - 315

EP - 324

JO - Annali dell'Istituto Superiore di Sanita

JF - Annali dell'Istituto Superiore di Sanita

SN - 0021-2571

IS - 3

ER -